Alexion, Pfizer sign $1 billion accord for genomic medicines
HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for
HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for
HQ Team July 29, 2023: Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio,
HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to
HQ Team July 26, 2023: Better access to testing and diagnostic services is required to prevent sexually transmitted infections (STI) being acquired by
HQ Team July 25, 2023: At least 2.5 million people died because of drowning in the last decade and 90% of these deaths
HQ Team July 25, 2023: Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to
HQ Team July 25, 2023: Sixty-seven percent of Sudan’s hospitals are out of service and 10 healthcare workers have died in the internal
HQ Team July 25, 2023: The Middle East Respiratory Syndrome Coronavirus has killed 12 people in the UAE and infected 94 others from
HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and